Port Erin Biopharma Investments Ltd Share Price London S.E.
Equities
IM00B6QH1J21
Investment Management & Fund Operators
Sales 2022 | 6.42M 8.05M 672M | Sales 2023 | 29.7M 37.21M 3.11B | Capitalization | 104M 130M 10.83B |
---|---|---|---|---|---|
Net income 2022 | 8M 10.02M 836M | Net income 2023 | 22M 27.56M 2.3B | EV / Sales 2022 | 1.58 x |
Net cash position 2022 | 146M 183M 15.29B | Net cash position 2023 | 170M 213M 17.76B | EV / Sales 2023 | -2.23 x |
P/E ratio 2022 |
17.6
x | P/E ratio 2023 |
4.73
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 83.97% |
Managers | Title | Age | Since |
---|---|---|---|
Denham Eke
DFI | Director of Finance/CFO | 73 | 30/12/30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jim Mellon
FOU | Founder | 68 | 03/11/03 |
Richard Reed
BRD | Director/Board Member | 51 | 31/19/31 |
David Giampaolo
BRD | Director/Board Member | 65 | 31/19/31 |
1st Jan change | Capi. | |
---|---|---|
+31.41% | 12.02B | |
+14.40% | 3.06B | |
+1.75% | 1.42B | |
-8.46% | 1.22B | |
+1.15% | 616M | |
+36.04% | 577M | |
-4.17% | 492M | |
+33.85% | 488M | |
+3.90% | 304M |